The rising prevalence of opioid use disorder (OUD) among those living in the United States has demanded a collaborative response from health care and policy spheres. Addressing OUD among pregnant women is especially difficult, given the controversies surrounding the medical and ethical balance between meeting maternal versus fetal/newborn needs. Most medical organizations discourage the criminalization of drug use in pregnancy due to the adverse public health outcomes of such an approach. Despite this recommendation, many states continue to use punitive law to address drug use in pregnancy. In 2014, the Fetal Assault Law in Tennessee (TN) became the first law in the United States to directly allow women to be prosecuted for drug use in pregnancy. Since its expiration in 2016, this law has been re-introduced several times to the TN legislature in support of permanent implementation. This article outlines the impact of the initial Fetal Assault Law on maternal/newborn health in TN and provides alternative immediate, short-term, and long-term health policy strategies through which health care providers and legislators can better advocate for the well-being of both mothers with OUD and their infants.
American College of Obstetrics and Gynecologists. (2014). 2014 ACOG workforce task sheet: Tennessee. www.acog.org
2.
American College of Obstetricians and Gynecologists. (2017). Committee opinion No. 711: Opioid use and opioid use disorder in pregnancy.
3.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.).
Washington, DC.
4.
ArnaudoC. L.Andraka-ChristouB.AllgoodK. (2017).
Psychiatric co-morbidities in pregnant women with opioid use disorders: Prevalence, impact, and implications for treatment.Current Addiction Reports,
4(1), 1–13. https://doi.org/10.1007/s40429-017-0132-4
5.
AtkinsD. N.DurranceC. P. (2020).
State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals.Health Affairs (Project Hope),
39(5), 756–763. https://doi.org/10.1377/hlthaff.2019.00785
6.
BachW. A. (2019).
Prosecuting poverty, criminalizing care. William & Mary Law Review,
60(3), 809–890.
7.
BellJ.TowersC. V.HennessyM. D.HeitzmanC.SmithB.ChattinK. (2016).
Detoxification from opiate drugs during pregnancy. American Journal of Obstetrics and Gynecology,
215(3), 374.e371–376.e371. https://doi.org/10.1016/j.ajog.2016.03.015
8.
BetancourtL. M.YangW.BrodskyN. L.GallagherP. R.MalmudE. K.GiannettaJ. M.FarahM. J.HurtH. (2011).
Adolescents with and without gestational cocaine exposure: Longitudinal analysis of inhibitory control, memory and receptive language.Neurotoxicol Teratol,
33(1), 36–46. https://doi.org/10.1016/j.ntt.2010.08.004
9.
BrooklynJ. R.SigmonS. C. (2017).
Vermont hub-and-spoke model of care for opioid use disorder: Development, implementation, and impact.Journal of Addiction Medicine,
11(4), 286–292. https://doi.org/10.1097/ADM.0000000000000310
CockroftJ. D.AdamsS. M.BonnetK.MatlockD.McMillanJ.SchlundtD. (2019).
“A scarlet letter”: Stigma and other factors affecting trust in the health care system for women seeking substance abuse treatment in a community setting. Substance Abuse,
40(2), 170–177. https://doi.org/10.1080/08897077.2018.1544184
14.
Comprehensive Addiction and Recovery Act of 2016, S. 524, 114th Cong. (2016).
15.
DavisM. (2018).
Bad moms and powerful prosecutors: Why public health approach to maternal drug use is necessary to lessen the hardship borne by women in the South. Georgetown Journal on Poverty Law and Policy,
25(2), 305–322.
DowellD.HaegerichT. M.ChouR. (2016).
CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recommendations and Report,
65(1), 1–49. https://doi.org/10.15585/mmwr.rr6501e1
19.
DugganE. (2016)
A velvet hammer: The criminalization of motherhood and the new maternalism. California Law Review,
104(5), 1299–1332. https://doi.org/10.15779/Z38X28D
20.
EckholmE. (2014, April 14).
Specialists join call for veto of drug bill.The New York Times. https://perma.cc/R9DL-J2BT
21.
EylerF. D.BehnkeM.GarvanC. W.WoodsN. S.WobieK.ConlonM. (2001).
Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicology and Teratology,
23(5), 399–411. https://doi.org/10.1016/s0892-0362(01)00166-0
22.
FahertyL. J.KranzA. M.Russell-FritchJ.PatrickS. W.CantorJ.SteinB. D. (2019).
Association of punitive and reporting state policies related to substance use in pregnancy with rates of Neonatal Abstinence Syndrome. JAMA Netw Open,
2(11), e1914078. https://doi.org/10.1001/jamanetworkopen.2019.14078
23.
FellnerF. (2009).
Race, drugs, and law enforcement in the United States. Stanford Law & Policy Review,
20, 257.
24.
GhertnerR.BaldwinM.CrouseG.RadelL.WatersA. (2018). The relationship between substance use indicators and child welfare caseloads.
Department of Health & Human Services. https://perma.cc/YJN7-EQL3
25.
GoldensohnR.LevyR. (2015, February 15). A Tennessee law makes motherhood a crime. Facing South.https://perma.cc/88LP-HHWG
26.
GonzalezT. (2014, April 25). Haslam receives petition asking for veto of bill criminalizing prenatal drug use. Tennessean.https://perma.cc/L35U-4YDZ
27.
GroganC. M.BersamiraC. S.SingerP. M.SmithB. T.PollackH. A.AndrewsC. M.AbrahamA. J. (2020).
Are policy strategies for addressing the opioid epidemic partisan? A view from the states.Journal of Health Politics, Policy and Law,
45(2), 277–309. https://doi.org/10.1215/03616878-8004886
28.
HaightS. C.KoJ. Y.TongV. T.BohmM. K.CallaghanW. M. (2018)
Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morbidity and Mortality Weekly Report,
67, 845–849. https://doi.org/10.15585/mmwr.mm6731a1
29.
HaleS.ZelinskiA. (2014, May 8). By signing the controversial SB 1391, Gov. Bill Haslam makes Tennessee a battleground over the rights of pregnant women and prosecutorial bounds. Nashville Scene.https://perma.cc/WC7Z-KCCW
HowardH. (2016).
Experiences of opioid-dependent women in their prenatal and postpartum care: Implications for social workers in health care.Social Work in Health Care,
55(1), 61–85. https://doi.org/10.1080/00981389.2015.1078427
HuiK.AngelottaC.FisherC. E. (2017).
Criminalizing substance use in pregnancy: Misplaced priorities.Addiction,
112(7), 1123–1125. https://doi.org/10.1111/add.13776
38.
HumphreysK. (2017).
How to deliver a more persuasive message regarding addiction as a medical disorder. Journal of Addiction Medicine,
11(3), 174–175. https://doi.org/10.1097/ADM.0000000000000306
39.
JessupM. A.OertherS. E.Gance-ClevelandB.ClevelandL. M.CzubarukK. M.ByrneM. W., . . . Martinez-RogersN. (2019).
Pregnant and parenting women with a substance use disorder: Actions and policy for enduring therapeutic practice.Nursing Outlook,
67(2), 199–204. https://doi.org/10.1016/j.outlook.2019.02.005
40.
Joint Task Force to Combat Opioid Trafficking Act of 2018, H.R. 5762, 115th Cong. 2nd Sess. (2018).
41.
JonesC. M.McCance-KatzE. F. (2019).
Co-occurring substance use and mental disorders among adults with opioid use disorder.Drug and Alcohol Dependence,
197, 78–82. https://doi.org/10.1016/j.drugalcdep.2018.12.030
42.
Kaiser Family Foundation. (2018). Medicaid behavioral health services: Substance use disorder (SUD) services.www.kff.org
43.
KoJ.PatrickS.TongV.PatelR.LindJ.BarfieldW. (2016).
Incidence of neonatal abstinence syndrome — 28 states, 1999–2013. MMWR Morbidity and Mortality Weekly Report,
65, 799–802. https://doi.org/10.15585/mmwr.mm6531a2
44.
KozhimannilK. B.AdmonL. K. (2019).
Structural factors shape the effects of the opioid epidemic on pregnant women and infants.Journal of the American Medical Association,
321(4), 352–353. https://doi.org/10.1001/jama.2018.20395
45.
KransE. E.PatrickS. W. (2016).
Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic.Obstetrics & Gynecology,
128(1), 4–10. https://doi.org/10.1097/AOG.0000000000001446
46.
KremerM. E.AroraK. S. (2015).
Clinical, ethical, and legal considerations in pregnant women with opioid abuse.Obstetrics & Gynecology,
126(3), 474–478. https://doi.org/10.1097/aog.0000000000000991
47.
LoganB. A.BrownM. S.HayesM. J. (2013).
Neonatal abstinence syndrome: Treatment and pediatric outcomes.Clinical Obstetrics and Gynecology,
56(1), 186–192. https://doi.org/10.1097/GRF.0b013e31827feea4
48.
MartinP. R.FinlaysonA. J. R. (2015).
Opioid use disorder during pregnancy in Tennessee: Expediency vs. science.The American Journal of Drug and Alcohol Abuse,
41(5), 367–370. https://doi.org/10.3109/00952990.2015.1047502
49.
MasonR.O’RinnS. E. (2014).
Co-occurring intimate partner violence, mental health, and substance use problems: A scoping review.Global Health Action,
7, 24815. https://doi.org/10.3402/gha.v7.24815
50.
McNeelyC. A.HutsonS.SturdivantT. L.JabsonJ. M.IsabellB. S. (2019).
Expanding contraceptive access for women with substance use disorders: Partnerships between public health departments and county jails.Journal of Public Health Management and Practice,
25(3), 2–237. https://doi.org/10.1097/phh.0000000000000850
51.
MeschkeL. L.McNeelyC.BrownK. C.PratherJ. M. (2018).
Reproductive health knowledge, attitudes, and behaviors among women enrolled in Medication-Assisted Treatment for opioid use disorder.Journal of Women’s Health (Larchmt),
27(10), 1215–1224. https://doi.org/10.1089/jwh.2017.6564
52.
MooreD. J. (2019).
Nurse practitioner’s pivotal role in ending the opioid epidemic. The Journal for Nurse Practitioners,
15(5), 323–327. https://doi.org/10.1016/j.nurpra.2019.01.005
53.
National Institute for Health Care Management. (2015). Reducing Neonatal Abstinence Syndrome in Tennessee. https://perma.cc/C8X2-V35T
54.
National Advocates for Pregnant Women. (2018). Medical and public health group statements opposing prosecution and punishment of pregnant women. https://perma.cc/LVT3-UFLW
Neonatal Abstinence Syndrome. (2019). Hearings before the Health and Welfare Committee, 111th Tennessee Senate (2019) (Testimony of Dr. Craig Towers). https://perma.cc/YF2S-N4HF
57.
NORC at the University of Chicago. (2020). Drug overdose deaths in the United States [Interactive Map]. https://opioidmisusetool.norc.org/
58.
NyakerigaA. M.McDonaldM. (2019). Neonatal abstinence syndrome surveillance annual report 2019.
Tennessee Department of Health.
59.
O’BrienC. (2011).
Addiction and dependence in DSM-V.Addiction,
106(5), 866–867.
60.
OstrachB.LeinerC. (2019).
“I didn’t want to be on Suboxone at first…”—Ambivalence in perinatal substance use treatment.Journal of Addiction medicine,
13(4), 264–271. https://doi.org/10.1097/adm.0000000000000491
61.
PatrickS. W.BuntinM. B.MartinP. R.ScottT. A.DupontW.RichardsM.CooperW. O. (2018).
Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states. Substance Abuse,
40(3), 356–362. https://doi.org/10.1080/08897077.2018.1488336
62.
PatrickS. W.DudleyJ.MartinP. R.HarrellF. E.WarrenM. D.HartmannK. E., . . . CooperW. O. (2015).
Prescription opioid epidemic and infant outcomes. Pediatrics,
135(5), 842–850. https://doi.org/10.1542/peds.2014-3299
63.
PatrickS. W.FahertyL. J.DickA. W.ScottT. A.DudleyJ.SteinB. D. (2019).
Association among county-level economic factors, clinician supply, metropolitan or rural location, and neonatal abstinence syndrome.Journal of the American Medical Association,
321(4), 385–393. https://doi.org/10.1001/jama.2018.20851
64.
PatrickS. W.SchiffD. M. (2017).
A public health response to opioid use in pregnancy. Pediatrics,
139(3), e20164070. https://doi.org/10.1542/peds.2016-4070
PolandM. L.DombrowskiM. P.AgerJ. W.SokolR. J. (1993).
Punishing pregnant drug users: Enhancing the flight from care. Drug and Alcohol Dependence,
31(3), 199–203. https://doi.org/10.1016/0376-8716(93)90001-7
ReddyU. M.DavisJ. M.RenZ.GreeneM. F., & Workshop Speakers. (2017).
Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: Executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation.Obstetrics & Gynecology,
130(1), 10–28. https://doi.org/10.1097/AOG.0000000000002054
73.
Safe Harbor Act of 2013. Tenn. Code Ann. § Section 33-10-104(f) (2013).
74.
SanlorenzoL. A.StarkA. R.PatrickS. W. (2018).
Neonatal Abstinence Syndrome: An update.Current Opinion in Pediatrics,
30(2), 182–186. https://doi.org/10.1097/mop.0000000000000589
75.
SaundersJ. B.JarlenskiM. P.LevyR.KozhimannilK. B. (2018).
Federal and state policy efforts to address maternal opioid misuse: Gaps and challenges.Womens Health Issues,
28(2), 130–136. https://doi.org/10.1016/j.whi.2017.10.011
SchiffD. M.PatrickS. W. (2017).
Treatment of opioid use disorder during pregnancy and cases of neonatal abstinence syndrome.JAMA Pediatrics,
171(7), 707. https://doi.org/10.1001/jamapediatrics.2017.0854
ShearerJ. N.ErwinP.C.DavisS. K.AndersonJ. G.LindleyL. C. (2019).
Implications of Tennessee’s opioid legislation for neonatal abstinence syndrome.Policies, Politics, & Nursing Practice.
20(3) 153–162. https://doi.org/10.1177/1527154419864540
84.
SmithD.HanlonC. (2017). Case study: Tennessee’s perinatal episode of care payment strategy promotes improved birth outcomes.
National Academy for State Health Policy. https://perma.cc/Y9X7-XA2R
85.
SoderbergV. R. (2016).
More than receptacles: An international human rights analysis of criminalizing pregnancy in the United States. Berkeley Journal of Gender, Law & Justice,
31(2), 299–351.
86.
SoelbergC. D.BrownR. E.Du VivierD.MeyerJ. E.RamachandranB. K. (2017).
The US opioid crisis: Current federal and state legal issues.Anesthesia & Analgesia,
125(5), 1675–1681. https://doi.org/10.1213/ane.0000000000002403
87.
SpringerD. (2014). Drug-addicted mothers need access to treatment. The Chattanoogan. https://perma.cc/Y4WR-NW8F
88.
Substance Abuse and Mental Health Services Administration. (2018). Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants (HHS Publication No (SMA) 18-5054).
89.
The Sycamore Institute. (2018). The opioid epidemic in Tennessee: 2018 update on new policy actions. https://perma.cc/BFW4-2UH9
90.
Tenn. Code Ann. § Section 39-17-402. (2019).
91.
Tennessee State Government. (n.d.) TN together: A comprehensive plan to end the opioid crisis in Tennessee.https://perma.cc/4L97-VGNU
92.
TerplanM.LairdH. J.HandD. J.WrightT. E.PremkumarA.MartinC. E.MeyerM. C.JonesH. E.KransE. E. (2018).
Opioid detoxification during pregnancy: A systematic review.Obstetrics & Gynecology,
131(5), 803–814. https://doi.org/10.1097/AOG.0000000000002562
93.
TetlockP. E.MitchellG. (1993). Liberal and conservative approaches to justice: Conflicting psychological portraits. In B. A. Mellers & J. Baron (Eds.), Psychological perspectives on justice: Theory and applications (pp. 234–255).
Cambridge University Press.
94.
ThomasS.TreffersR.BerglasN.DrabbleL.RobertsS. (2018).
Drug use during pregnancy policies in the United States from 1970 to 2016. Contemporary Drug Problems,
45(4), 441–459. https://doi.org/10.1177/0091450918790790
TowersC. V.KatzE.LiskeE.HennessyM.WolfeL.ViscontiK. (2020).
Psychosocial background history of pregnant women with opioid use disorder: A prospective cohort study.American Journal of Perinatology,
37(9), 924–928. https://doi.org/10.1055/s-0039-1689001
97.
WahlerE. A. (2015).
Retribution or rehabilitation? Conflicting goals of US policies pertaining to drug felonies and their impact on women. Journal of Women, Politics & Policy,
36(1), 95–106. https://doi.org/10.1080/1554477X.2015.985155
98.
WarrenM. D.MillerA. M.TraylorJ.BauerA.PatrickS. W. (2015).
Implementation of a statewide surveillance system for neonatal abstinence syndrome—Tennessee, 2013. MMWR Morbidity and Mortality Weekly Report,
64(5), 125–128.
99.
WoodworthA. M.McLellanA. T. (2016).
Converging advances in science, policy and public awareness: A time of great opportunity and change in addiction treatment. Brain Research Bulletin,
123, 110–113. https://doi.org/10.1016/j.brainresbull.2016.05.00
